Skip to content

Clinical trials

Phase 2 Autoimmune Diseases trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Country / region: Sweden Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20131
20171
20181
20192
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Diamyd Medical AB2
Diamyd Therapeutics AB2
Novartis Pharmaceuticals2
Angelica Lindén Hirschberg1
AstraZeneca1
Imcyse SA1
Immunovant Sciences GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases10
Diabetes Mellitus, Type 14
Immune System Diseases3
Metabolic Diseases2
Arthritis, Rheumatoid1
Demyelinating Diseases1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Endocrine System Diseases1
Fatigue1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.